| Index | — | P/E | 70.93 | EPS (ttm) | 3.57 | Insider Own | 2.15% | Shs Outstand | 58.30M | Perf Week | 7.12% |
| Market Cap | 14.76B | Forward P/E | 41.02 | EPS next Y | 6.17 | Insider Trans | -0.85% | Shs Float | 57.45M | Perf Month | 24.04% |
| Enterprise Value | 14.62B | PEG | 5.69 | EPS next Q | 1.39 | Short Float | 5.75% | Perf Quarter | 33.68% | ||
| Income | 212.00M | P/S | 12.77 | EPS this Y | 11.80% | Short Ratio | 4.31 | Perf Half Y | 79.88% | ||
| Sales | 1.16B | P/B | 73.45 | EPS next Y | 10.81% | ROA | 28.36% | Short Interest | 3.31M | Perf YTD | 46.11% |
| Book/sh | 3.45 | P/C | 74.19 | EPS next 5Y | 12.46% | ROE | 96.99% | 52W High | 259.76 -2.52% | Perf Year | 40.78% |
| Cash/sh | 3.41 | P/FCF | 38.85 | EPS past 3/5Y | 21.04% 21.49% | ROIC | 76.30% | 52W Low | 119.06 112.68% | Perf 3Y | 31.94% |
| Dividend Est. | — | EV/EBITDA | 49.55 | Sales past 3/5Y | 12.12% 13.03% | Gross Margin | 54.94% | Volatility | 4.33% 3.38% | Perf 5Y | 48.88% |
| Dividend TTM | — | EV/Sales | 12.64 | EPS Y/Y TTM | 1.71% | Oper. Margin | 24.14% | ATR (14) | 8.52 | Perf 10Y | 386.49% |
| Dividend Ex-Date | — | Quick Ratio | 1.07 | Sales Y/Y TTM | 8.34% | Profit Margin | 18.41% | RSI (14) | 74.54 | Recom | 2.20 |
| Dividend Gr. 3/5Y | — | Current Ratio | 1.07 | EPS Q/Q | 13.97% | SMA20 | 11.22% | Beta | 0.82 | Target Price | 256.67 |
| Payout | 0.00% | Debt/Eq | 0.26 | Sales Q/Q | 10.87% | SMA50 | 16.50% | Rel Volume | 0.96 | Prev Close | 248.39 |
| Employees | 4,370 | LT Debt/Eq | 0.26 | Earnings | Jan 26 | SMA200 | 51.87% | Avg Volume | 746.24K | Price | 253.22 |
| IPO Date | Apr 23, 1998 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 5.89% 3.09% | Net Debt/EBITDA | -0.50 | Volume | 716,803 | Change | 1.94% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-28-26 | Reiterated | UBS | $240 → $305 | |
| Oct-28-26 | Reiterated | Stifel Nicolaus | $225 → $300 | |
| Oct-12-26 | Upgrade | Morgan Stanley | Equal Weight → Overweight | $180 → $250 |
| Sep-28-26 | Reiterated | UBS | $240 → $210 | |
| Sep-28-26 | Downgrade | DA Davidson | Buy → Neutral | |
| Aug-26-26 | Reiterated | Robert W. Baird | $218 → $260 | |
| Jul-29-26 | Reiterated | Morgan Stanley | Equal Weight | $165 → $180 |
| Jul-29-26 | Reiterated | Stifel Nicolaus | $200 → $225 | |
| Jul-29-26 | Reiterated | DA Davidson | Buy | $250 → $210 |
| Jul-29-26 | Upgrade | Loop Capital | Hold → Buy | $265 → $215 |
Manhattan Associates, Inc. develops comprehensive software solutions to manage and optimize supply chains, inventory, and omni-channel operations. Their product portfolio features Manhattan SCALE, a suite of logistics execution tools covering aspects like trading partner management, yard optimization, warehouse management, and transportation execution. Additionally, they offer Manhattan Active, which provides integrated enterprise and in-store omni-channel solutions. The company also supplies specialized solutions for inventory optimization, planning, and allocation. Supporting these offerings are a range of services, including ongoing maintenance (customer support and software enhancements), professional services (solution planning, implementation, and consulting), and training and change management programs. Beyond software, Manhattan Associates also resells complementary hardware such as computer equipment, radio frequency (RF) terminal networks, RFID readers, barcode printers and scanners, and other peripherals. They distribute their products through a direct sales force and via strategic partnership agreements. Serving a diverse global clientele, their industry reach includes grocery, food and beverage, manufacturing, medical and pharmaceutical, retail, third-party logistics (3PLs), and wholesale. With operations spanning the Americas, Europe, the Middle East, Africa, and the Asia Pacific, Manhattan Associates, Inc. was founded in 1990 and is headquartered in Atlanta, Georgia.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,156 | 1,081 | 1,042 | 929 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 521 | 479 | 477 | 436 | — | — | — | — | — | |
| Gross Profit | 635 | 603 | 565 | 492 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 206 | 175 | 166 | 156 | — | — | — | — | — | |
| Research and Development | 147 | 145 | 138 | 127 | — | — | — | — | — | |
| Other Operating Expense | 3 | 0 | -1 | -1 | — | — | — | — | — | |
| Operating Income | 279 | 283 | 262 | 210 | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 8 | 3 | 5 | 4 | — | — | — | — | — | |
| Net Income Before Taxes | 287 | 286 | 267 | 214 | — | — | — | — | — | |
| Income Taxes | 75 | 66 | 48 | 37 | — | — | — | — | — | |
| Consolidated Net Income | 212 | 220 | 218 | 177 | — | — | — | — | — | |
| Net Income From Continuing Operations | 212 | 220 | 218 | 177 | — | — | — | — | — | |
| Net Income | 212 | 220 | 218 | 177 | — | — | — | — | — | |
| EPS (Recurring) | 3.60 | 3.64 | 3.56 | 2.86 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 3.60 | 3.64 | 3.56 | 2.86 | — | — | — | — | — | |
| EPS (Diluted) | 3.57 | 3.60 | 3.51 | 2.82 | — | — | — | — | — | |
| EBITDA | 295 | 292 | 273 | 219 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 70.93 | 48.14 | 76.99 | 76.35 | — | — | — | — | — | |
| Price To Sales Ratio | 12.70 | 9.62 | 15.82 | 14.37 | — | — | — | — | — | |
| Gross Margin | 54.93 | 55.78 | 54.22 | 52.96 | — | — | — | — | — | |
| Operating Margin | 24.13 | 26.18 | 25.14 | 22.60 | — | — | — | — | — | |
| Net Margin | 18.34 | 20.35 | 20.92 | 19.05 | — | — | — | — | — | |
| Shares Outstanding | 58 | 60 | 61 | 62 | — | — | — | — | — | |
| Market Capitalization | 14,687 | 10,399 | 16,485 | 13,350 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Clark Eric Andrew | President & CEO | Aug 11 '26 | Sale | 197.76 | 3,000 | 593,280 | 89,638 | Aug 11 |
| Hollembaek Linda T. | Director | Aug 06 '26 | Sale | 189.88 | 1,579 | 299,821 | 12,268 | Aug 10 |
| Gantt James Stewart | EVP, Professional Services | Jul 30 '26 | Sale | 195.53 | 5,139 | 1,004,831 | 55,676 | Jul 31 |
| Clark Eric Andrew | President & CEO | Jun 10 '26 | Sale | 146.77 | 1,000 | 146,770 | 92,638 | Jun 10 |
| Gantt James Stewart | EVP, Professional Services | Apr 24 '26 | Sale | 139.25 | 7,300 | 1,016,525 | 60,815 | Apr 24 |
| Clark Eric Andrew | President & CEO | Nov 28 '25 | Sale | 176.40 | 1,600 | 282,235 | 50,486 | Dec 01 |
| Gantt James Stewart | EVP, Professional Services | Aug 28 '25 | Sale | 218.70 | 2,300 | 503,006 | 49,168 | Sep 02 |
| Capel Eddie | Executive Chairman | Jul 29 '25 | Sale | 222.18 | 37,342 | 8,296,577 | 162,988 | Jul 31 |
| Hollembaek Linda T. | Director | Jul 29 '25 | Sale | 221.53 | 2,024 | 448,380 | 11,907 | Jul 31 |
| Gantt James Stewart | EVP, Professional Services | Jul 25 '25 | Sale | 220.33 | 2,300 | 506,759 | 48,660 | Jul 29 |
| STORY DENNIS B | EVP, CFO & Treasurer | Mar 06 '25 | Sale | 170.83 | 2,788 | 476,265 | 101,263 | Mar 10 |
| Richards Bruce | SVP, CLO & Secretary | Nov 29 '24 | Sale | 289.73 | 4,150 | 1,202,397 | 22,086 | Dec 03 |
| Gantt James Stewart | EVP, Professional Services | Nov 26 '24 | Sale | 288.10 | 3,475 | 1,001,138 | 42,812 | Nov 29 |
| Eger Edmond | Director | Nov 06 '24 | Sale | 282.06 | 2,675 | 754,504 | 10,864 | Nov 08 |
| Richards Bruce | SVP, CLO & Secretary | Aug 29 '24 | Sale | 261.00 | 1,527 | 398,547 | 26,236 | Aug 30 |